Market Overview

UPDATE: Wedbush Initiates Intuitive Surgical at Outperform on Market Leader Position

Share:
Related ISRG
Greenlight Capital's Q2 Investor Letter: Brexit, Central Bank's 'Failing Policies,' Top Stock Picks And More
Following Intuitive Surgical's Solid Q2, Citi Asks What's Next
Sam Isaly Swaps ' Health Care Stocks in Second Quarter (GuruFocus)

In a report published Tuesday, Wedbush analyst Tao Levy initiated coverage on Intuitive Surgical (NASDAQ: ISRG) with an Outperform rating and $580.00 price target.

In the report, Wedbush noted, “Intuitive Surgical is the leader in the robotic surgery market with its da Vinci Surgical System, generating over $2 billion in revenues that we expect to grow at a 3-year CAGR of 16%. The company is highly profitable (operating profit margin of approximately 40%), with a pristine balance sheet that holds a net cash & investments position of $3+ billion ($75/share). While ISRG has encountered mounting criticisms from multiple parties, we find the risk/reward profile attractive at current levels. Our bullish outlook is predicated on the underpenetrated procedure opportunity, ongoing launch of new instruments and accessories, and ISRG's track record of innovation and new product development.”

Intuitive Surgical closed on Monday at $499.32.

Latest Ratings for ISRG

DateFirmActionFromTo
Jul 2016BarclaysMaintainsOverweight
Jul 2016CitigroupMaintainsBuy
Jun 2016Goldman SachsDowngradesBuyNeutral

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: Tao Levy WedbushAnalyst Color Initiation Analyst Ratings

 

Related Articles (ISRG)

View Comments and Join the Discussion!